NCT00015457View on ClinicalTrials.gov

Amlodipine Plus Botulinum Toxin for Focal Dystonia

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

April 30, 2009

Conditions
Focal Dystonia
Interventions
DRUG

Amlodipine plus Botulinum toxin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00015457 - Amlodipine Plus Botulinum Toxin for Focal Dystonia | Biotech Hunter | Biotech Hunter